RismadarVoice Reporters
September 26, 2026
Supplies of the twice-yearly HIV-prevention injection Lenacapavir have reportedly run out in four Nigerian states following increased demand months after its introduction under a Federal Government pilot programme.
The shortages were reported in Benue, Kwara, Gombe and Cross River states, where demand for the long-acting injection has reportedly exceeded available supplies.
In Cross River, health workers reported particularly strong demand among sex workers, some of whom prefer the injection because it offers a more discreet and convenient alternative to taking daily oral pre-exposure prophylaxis, commonly known as PrEP.
Lenacapavir is administered twice yearly and can significantly reduce the risk of sexually acquired HIV when used for prevention by eligible HIV-negative individuals.
Nigeria began rolling out the injection in selected states as part of efforts to expand HIV-prevention options for populations at increased risk of infection.
The reported stock-outs have raised concerns over whether supplies can keep pace with demand as awareness and uptake increase.
The situation, however, varies across participating states.
In Lagos, health authorities reportedly have sufficient supplies but have recorded relatively low uptake, prompting calls for eligible residents to take advantage of the programme.
The contrasting experiences highlight challenges facing the rollout, with some states experiencing supply shortages while others seek to increase public awareness and uptake.
Lenacapavir forms part of broader HIV-prevention efforts aimed at providing longer-lasting alternatives for people who may have difficulty consistently taking daily preventive medication.
